The stock of Aurora Cannabis Inc (ACB) has gone up by 12.44% for the week, with a -16.49% drop in the past month and a 12.70% rise in the past quarter. The volatility ratio for the week is 4.36%, and the volatility levels for the past 30 days are 6.11% for ACB. The simple moving average for the past 20 days is 0.04% for ACB’s stock, with a -7.97% simple moving average for the past 200 days.
Is It Worth Investing in Aurora Cannabis Inc (NASDAQ: ACB) Right Now?
The price-to-earnings ratio for Aurora Cannabis Inc (NASDAQ: ACB) is above average at 30.68x, Company’s 36-month beta value is 1.65.Analysts have differing opinions on the stock, with 3 analysts rating it as a “buy,” 1 as “overweight,” 3 as “hold,” and 0 as “sell.”
The public float for ACB is 54.67M, and currently, short sellers hold a 8.60% ratio of that floaft. The average trading volume of ACB on March 20, 2025 was 2.89M shares.
ACB) stock’s latest price update
Aurora Cannabis Inc (NASDAQ: ACB) has experienced a rise in its stock price by 11.41 compared to its previous closing price of 4.34. However, the company has seen a gain of 12.44% in its stock price over the last five trading days. prnewswire.com reported 2025-03-20 that NASDAQ | TSX: ACB Groundbreaking research at Aurora Coast, Aurora’s world-class research and development facility, sets new standard in cannabis science EDMONTON, AB, March 20, 2025 /PRNewswire/ – Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, is pleased to announce the Company’s discovery of a novel source of genetic resistance against powdery mildew, PM2, that provides strong protection against this pathogen in cannabis sativa. The development of this proprietary genetic marker technology, which is now in use in Aurora’s breeding program, is set to produce powdery mildew resistant cultivars that will be explored for commercial launch this year.
ACB Trading at 1.34% from the 50-Day Moving Average
After a stumble in the market that brought ACB to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -48.29% of loss for the given period.
Volatility was left at 6.11%, however, over the last 30 days, the volatility rate increased by 4.36%, as shares sank -17.45% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +3.81% upper at present.
During the last 5 trading sessions, ACB rose by +12.50%, which changed the moving average for the period of 200-days by -21.85% in comparison to the 20-day moving average, which settled at $4.83. In addition, Aurora Cannabis Inc saw 13.76% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for ACB
Current profitability levels for the company are sitting at:
- -0.16 for the present operating margin
- 0.54 for the gross margin
The net margin for Aurora Cannabis Inc stands at -0.23. The total capital return value is set at -0.04. Equity return is now at value 4.78, with 3.09 for asset returns.
Based on Aurora Cannabis Inc (ACB), the company’s capital structure generated 0.16 points at debt to capital in total, while cash flow to debt ratio is standing at -0.55. The debt to equity ratio resting at 0.19. The interest coverage ratio of the stock is -3.59.
Currently, EBITDA for the company is 20.47 million with net debt to EBITDA at -0.41. When we switch over and look at the enterprise to sales, we see a ratio of 1.87. The receivables turnover for the company is 4.3for trailing twelve months and the total asset turnover is 0.23. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.30.
Conclusion
In a nutshell, Aurora Cannabis Inc (ACB) has experienced a better performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
